Blueshift Asset Management, LLC Dynavax Technologies Corp Transaction History

Blueshift Asset Management, LLC

  • $392 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$7.45 - $12.83 $134,539 - $231,696
-18,059 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$9.75 - $14.44 $176,075 - $260,771
18,059 New
18,059 $196,000
Q1 2021

May 06, 2021
SELL
$4.57 - $11.18 $190,893 - $466,999
-41,771 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$3.73 - $5.6 $155,805 - $233,917
41,771 New
41,771 $186,000

Others Institutions Holding DVAX

# of Institutions
275
Shares Held
130M
Call Options Held
451K
Put Options Held
203K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.63B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email